EXEL

Exelixis News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Exelixis Inc EXEL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.60 2.58% 23.84 00:00:07
Close Price Low Price High Price Open Price Previous Close
23.84 23.08 23.875 23.10 23.24
more quote information »

Recent News

Date Time Source Heading
9/21/202010:20BWExelixis Announces Results From Two Renal Cell Carcinoma..
9/19/202012:30BWOpdivo® (nivolumab) in Combination with CABOMETYX®..
9/15/202008:00BWExelixis & Iconic Therapeutics Announce Promising..
9/14/202008:00BWExelixis to Host Investor Briefing to Discuss Data Presented..
9/08/202016:05BWExelixis to Webcast Fireside Chats as Part of Virtual..
9/08/202008:05BWExelixis & NBE-Therapeutics Enter Into Exclusive..
9/08/202008:01BWExelixis & Catalent Enter into Collaboration, License, &..
9/04/202018:40EDGARStatement of Changes in Beneficial Ownership (4)
9/04/202018:39EDGARStatement of Changes in Beneficial Ownership (4)
9/04/202018:33EDGARStatement of Changes in Beneficial Ownership (4)
9/04/202018:32EDGARStatement of Changes in Beneficial Ownership (4)
8/24/202008:00BWExelixis Announces Submission of Supplemental New Drug..
8/14/202019:51EDGARStatement of Changes in Beneficial Ownership (4)
8/06/202016:37EDGARSecurities Registration: Employee Benefit Plan (s-8)
8/06/202016:16EDGARQuarterly Report (10-q)
8/06/202016:11EDGARCurrent Report Filing (8-k)
8/06/202016:05BWExelixis Announces Second Quarter 2020 Financial Results and..
7/29/202016:05BWExelixis to Release Second Quarter 2020 Financial Results on..
7/22/202019:06EDGARStatement of Changes in Beneficial Ownership (4)
7/22/202019:02EDGARStatement of Changes in Beneficial Ownership (4)
7/20/202008:00BWExelixis Announces Initiation of CONTACT-03 Phase 3 Pivotal..
6/30/202008:00BWExelixis Announces Initiation of CONTACT-02 Phase 3 Pivotal..
6/18/202016:05BWExelixis to Webcast Virtual Fireside Chat as Part of the..
6/11/202008:00BWExelixis Announces Initiation of CONTACT-01 Phase 3 Pivotal..
6/03/202016:05BWExelixis to Webcast Fireside Chats as Part of Virtual..
5/22/202017:21EDGARCurrent Report Filing (8-k)
5/13/202017:00BWExelixis Announces Results From COSMIC-021 Trial of..
5/12/202006:02EDGARCurrent Report Filing (8-k)
5/06/202016:05BWExelixis to Webcast Fireside Chats as Part of Virtual..
5/05/202016:17EDGARQuarterly Report (10-q)
5/05/202016:05BWExelixis Announces First Quarter 2020 Financial Results and..
4/30/202013:02EDGARConfidential Treatment Order (ct Order)
4/30/202013:02EDGARConfidential Treatment Order (ct Order)
4/21/202016:05BWExelixis to Release First Quarter 2020 Financial Results on..
4/20/202010:27DJNExelixis Shares Hit 52-Week High on Phase 3 Study Data
4/20/202007:50DJNBristol-Myers, Exelixis Phase 3 Kidney Cancer Study Meets..
4/20/202007:03EDGARCurrent Report Filing (8-k)
4/20/202006:59BWBristol Myers Squibb & Exelixis Announce Positive Topline..
4/09/202009:20EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/09/202009:17EDGARProxy Statement (definitive) (def 14a)
4/08/202016:05BWExelixis to Webcast Virtual Fireside Chat as Part of the..
3/25/202003:01BWExelixis Announces Partner Takeda Receives Approval in Japan..
3/02/202016:11EDGARCurrent Report Filing (8-k)
3/02/202016:05BWExelixis Announces George A. Scangos, Ph.D. to Retire From..
2/26/202016:05BWExelixis Announces Webcasts of Investor Conference..
2/25/202016:15EDGARAnnual Report (10-k)
2/25/202016:10EDGARCurrent Report Filing (8-k)
2/25/202016:06BWExelixis Announces First 100 Patients Enrolled in Phase 3..
2/25/202016:05BWExelixis Announces Fourth Quarter and Full Year 2019..
2/20/202017:06EDGARCurrent Report Filing (8-k)
See more news about this stock »
Your Recent History
NASDAQ
EXEL
Exelixis
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200928 06:46:18